FLT3 and acute myeloid leukemia: The aim of this study is to evaluate the impact of numerical variation, mutation length, allelic burden, and co-occurring mutations on clinical outcomes and to identify predictors of efficacy of TKI in combination with chemotherapy, in patients with newly diagnosed FLT3-ITD mutant AML.